Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Fuyong, Chu"'
Autor:
Wei, Wang, Xukun, Ma, Chulei, Fang, Na, Li, Wei, Tang, Fuyong, Chu, Ping, Jiang, Guoxiong, Mei
Publikováno v:
In Journal of Building Engineering 15 November 2024 97
Autor:
Fuyong Chu, Xue Yan, Xingjiang Xiong, Mingxue Zhou, Yupei Tan, Yixuan Li, Wei Liu, Hongxu Liu
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2022 (2022)
Background: Acute myocardial infarction (AMI) is the leading cause of malignant arrhythmia, heart failure, and sudden death. However, safe and effective drugs for the treatment of AMI are unavailable to date. The present study aimed to investigate th
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hongxu Liu, Yuyi Chen, Xing Su, Lumin Qiao, Yixuan Li, Wei Liu, Fuyong Chu, Xingjiang Xiong, Jie Wang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 131, Iss, Pp 110746-(2020)
This study investigated the therapeutic efficacy of Bu-Shen-Jiang-Ya decoction (BSJYD) on hypertensive renal damage to determine whether it regulates the expression of transforming growth factor-β (TGF-β)/SMADs signaling pathways, thereby relieving
Autor:
Fuyong Chu, Kelei Su, Pengqian Wang, Yanwei Xing, Hu You, Wei Liu, Xiaoke Li, Shengjie Li, Lian Duan, Xingjiang Xiong
Publikováno v:
Phytomedicine : international journal of phytotherapy and phytopharmacology. 61
Background Xiao Yao San (XYS) is thought to be beneficial for the treatment of hypertension in China. Purpose A systematic review and meta-analysis was performed to evaluate the efficacy and safety of XYS in hypertension. Study design A comprehensive
Publikováno v:
Complementary Therapies in Medicine. 23(1):100-115
SummaryBackgroundTo systematically assess the current clinical evidence of Zhigancao (ZGC) Decoction for premature ventricular contractions (PVCs).Search strategyPubMed, the Cochrane Center Controlled Trials Register, EMBASE, Chinese National Knowled
Autor:
Xiaoke Li, Xingjiang Xiong, Zhuyuan Fang, Fuyong Chu, Bo Feng, Xiaochen Yang, Weidong Qian, Haixia Li, Wei Liu, Jie Wang
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2013 (2013)
Evidence-Based Complementary and Alternative Medicine, Vol 2013 (2013)
Background. Yangxue Qingnao granule (YQG) combined with antihypertensive drugs, a new integrative medicine therapy, has been widely used for essential hypertension (EH) in China. This study aims to assess the current clinical evidence of YQG combined
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2016 (2016)
Evidence-Based Complementary and Alternative Medicine, Vol 2016 (2016)
We systematically assess the current clinical evidence of Gualouxiebaibanxia (GLXBBX) decoction for the treatment of angina pectoris (AP). We included RCTs testing GLXBBX against conventional drugs and GLXBBX combined with conventional drugs versus c
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2013 (2013)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Hypertension is a major public-health issue. Much consensus has been reached in the treatment, and considerable progress has been made in the field of antihypertensive drugs. However, the standard-reaching rate of blood pressure is far from satisfact
Autor:
Aiyong Li, Bao Wu, Hongxu Liu, Fuyong Chu, Juju Shang, Hongzhi Yang, Weihong Liu, Xinran Xie, Tong Tong
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2013 (2013)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Objectives.The study was to investigate the effects and mechanisms of Shen-Yuan-Dan (SYD) pharmacological postconditioning on myocardial ischemia/reperfusion (I/R) injury.Methods.In thein vivoexperiment, myocardial injury markers and histopathology s